首页> 外文期刊>Materials science & engineering >Mouse embryonic stem cells cultured under serum- and feeder-free conditions maintain their self-renewal capacity on hydroxyapatite
【24h】

Mouse embryonic stem cells cultured under serum- and feeder-free conditions maintain their self-renewal capacity on hydroxyapatite

机译:在无血清和无饲养层的条件下培养的小鼠胚胎干细胞在羟基磷灰石上保持自我更新的能力

获取原文
获取原文并翻译 | 示例
           

摘要

New tissue engineering techniques based on embryonic stem (ES) cells and artificial scaffolds are required for regenerative medicine. Because artificial scaffolds can regulate the differentiation states of ES cells, compatibility between the cells and artificial scaffolds is important. To our knowledge, this study is the first report showing that mouse ES (mES) cells can be maintained in undifferentiated state on hydroxyapatite coated with gelatin. In contrast to previous studies, our culture medium was serum-free and included a GSK-3 inhibitor. Under these conditions, mES colony morphology was similar to that of an undifferentiated state; mES cells expressed the pluripotent-specific factors Oct-3/4 and Nanog, and they maintained the ability to differentiate into the three germ layers. Moreover, a GSK-3 inhibitor blocked the expression of integrin subunits that bind to laminin which are known to induce the differentiation of mES cells. These findings indicate that mES cells can be cultured under serum- and feeder-free conditions and maintained in an undifferentiated state on a composite with hydroxyapatite and that this composite can be used to control the differentiation of stem cells.
机译:再生医学需要基于胚胎干(ES)细胞和人工支架的新组织工程技术。因为人工支架可以调节ES细胞的分化状态,所以细胞与人工支架之间的相容性很重要。据我们所知,这项研究是第一个报告,表明小鼠ES(mES)细胞可以在明胶包被的羟基磷灰石上保持未分化状态。与以前的研究相比,我们的培养基不含血清,并包含GSK-3抑制剂。在这些条件下,mES菌落形态与未分化状态相似。 mES细胞表达多能特异性因子Oct-3 / 4和Nanog,并且它们保持分化为三个胚层的能力。此外,GSK-3抑制剂可阻断与层粘连蛋白结合的整联蛋白亚基的表达,已知该蛋白可诱导mES细胞分化。这些发现表明,mES细胞可以在无血清和无饲养层的条件下培养,并在与羟基磷灰石的复合材料上保持未分化状态,并且该复合材料可以用于控制干细胞的分化。

著录项

  • 来源
    《Materials science & engineering》 |2014年第1期|214-220|共7页
  • 作者单位

    Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda, Tokyo 101-0062, Japan;

    Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda, Tokyo 101-0062, Japan,School of Science and Technology, Meiji University, 1-1-1 Higashimita, Tama, Kawasaki 214-8571, Japan;

    Bioresource Engineering Division, RIKEN BioResource Center, 3-1-1 Koyodai,Tsukuba-shi, Ibaraki 305-0074, Japan;

    Bioresource Engineering Division, RIKEN BioResource Center, 3-1-1 Koyodai,Tsukuba-shi, Ibaraki 305-0074, Japan;

    Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda, Tokyo 101-0062, Japan;

    School of Science and Technology, Meiji University, 1-1-1 Higashimita, Tama, Kawasaki 214-8571, Japan;

    Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda, Tokyo 101-0062, Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Hydroxyapatite; Scaffold; Mouse embryonic stem cell; Composite; GSK-3 inhibitor; Integrin;

    机译:羟基磷灰石;脚手架;小鼠胚胎干细胞;综合;GSK-3抑制剂;整合素;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号